Connect with FDA and CMS leaders to understand how regulatory changes will affect your biopharma, medtech, or medical device company.
For pharma or medical device executives bringing new products to market, keeping up with changes in FDA and CMS regulations can feel like a full-time job.
FDA/CMS Summit exists to help innovative organizations and startup founders better understand the current regulatory landscape. At this year's event, 350+ attendees will have the chance to hear from engaging speakers like Janet Woodcock, MD (Director, Center for Drug Evaluation & Research at the FDA), Lucas Kempf, (Associate Director - Rare Diseases Program at the FDA), Jeff Marrazzo (CEO of Spark Therapeutics), and many more.
During the two-day event, attendees will also have plenty of time to network and form new business connections with executives and entrepreneurs who are passionate about biotech, pharma, and medtech innovation.
EVENT INFORMATION:
Name of event: FDA/CMS Summit
Location: The Westin Washington, D.C. City Center 1400 M St NW, Washington, DC 20005
Date: December 11th, 2018 - December 12th, 2018
SPEAKER INFORMATION:
Adam Dakin, Managing Director - Dreamit HealthTech
Adam serves as the Managing Director of Dreamit HealthTech, a leading venture-backed accelerator. His career has focused on building early stage venture-backed healthtech companies. Adam has held various senior management roles in sales, marketing, product development, clinical affairs, operations, and general management. He co-founded five health technology companies which have collectively raised over $60M in early stage capital. Prior to Dreamit, Adam served as CEO of PhotoSonix Medical, a venture-backed company he co-founded that is developing a consumer device for acne. Previously, he served as the CEO of Bioconnect Systems and X-SITE Medical (acquired by Maquet Getinge Group). Adam serves on the boards of Safkan Ear and ZSX Medical. He is an active angel investor and has served on the boards of several early stage health companies. He is the co-chair of the Philadelphia Alliance for Capital and Technology (PACT) medical technology advisory board and serves as a Mentor in Residence for the Penn Center for Innovation. Adam was awarded the PACT MedTech Leadership Award in 2014. He is a named inventor on seven U.S. patents. Adam holds a BSE from the Wharton School and an MBA from UCLA.